Miriam
Giráldez Quiroga
Colaboradora Farmacéutica
Publicaciones (6) Publicaciones de Miriam Giráldez Quiroga
2021
2020
-
Single-Institution Experience in Clinical Trials during the COVID-19 Pandemic in Spain: Not So Bad after All?
JCO Global Oncology
-
The sars-cov-2 ivermectin navarra-isglobal trial (saint) to evaluate the potential of ivermectin to reduce covid-19 transmission in low risk, non-severe covid-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial
Trials, Vol. 21, Núm. 1
2019
-
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Nature Medicine, Vol. 25, Núm. 3, pp. 470-476
2013
-
The results of the pharmacosurveillance program in an oncological day hospital
Atencion Farmaceutica, Vol. 15, Núm. 1, pp. 59-62
2010
-
A single, fixed dose of rasburicase (6 mg maximum) for treatment of tumor lysis syndrome in adults
European Journal of Haematology